Global Influenza Daignostic Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Influenza Daignostic Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 Rapid Flu Detection Test
1.3.3 Virus Detection
1.3.4 Direct Fluorescent Antibody (DFA) Test
1.3.5 Serological Testing
1.4 Market by Application
1.4.1 Global Influenza Daignostic Market Share by Application: 2020 VS 2026
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Influenza Daignostic Market Perspective (2015-2026)
2.2 Influenza Daignostic Growth Trends by Regions
2.2.1 Influenza Daignostic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Influenza Daignostic Historic Market Share by Regions (2015-2020)
2.2.3 Influenza Daignostic Forecasted Market Size by Regions (2021-2026)
2.3 Influenza Daignostic Industry Dynamic
2.3.1 Influenza Daignostic Market Trends
2.3.2 Influenza Daignostic Market Drivers
2.3.3 Influenza Daignostic Market Challenges
2.3.4 Influenza Daignostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Influenza Daignostic Players by Market Size
3.1.1 Global Top Influenza Daignostic Players by Revenue (2015-2020)
3.1.2 Global Influenza Daignostic Revenue Market Share by Players (2015-2020)
3.2 Global Influenza Daignostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Influenza Daignostic Revenue
3.4 Global Influenza Daignostic Market Concentration Ratio
3.4.1 Global Influenza Daignostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Daignostic Revenue in 2019
3.5 Key Players Influenza Daignostic Area Served
3.6 Key Players Influenza Daignostic Product Solution and Service
3.7 Date of Enter into Influenza Daignostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Influenza Daignostic Breakdown Data by Type
4.1 Global Influenza Daignostic Historic Market Size by Type (2015-2020)
4.2 Global Influenza Daignostic Forecasted Market Size by Type (2021-2026)
5 Influenza Daignostic Breakdown Data by Application
5.1 Global Influenza Daignostic Historic Market Size by Application (2015-2020)
5.2 Global Influenza Daignostic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Influenza Daignostic Market Size (2015-2026)
6.2 North America Influenza Daignostic Market Size by Type (2015-2020)
6.3 North America Influenza Daignostic Market Size by Application (2015-2020)
6.4 North America Influenza Daignostic Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Influenza Daignostic Market Size (2015-2026)
7.2 Europe Influenza Daignostic Market Size by Type (2015-2020)
7.3 Europe Influenza Daignostic Market Size by Application (2015-2020)
7.4 Europe Influenza Daignostic Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Influenza Daignostic Market Size (2015-2026)
8.2 Asia-Pacific Influenza Daignostic Market Size by Type (2015-2020)
8.3 Asia-Pacific Influenza Daignostic Market Size by Application (2015-2020)
8.4 Asia-Pacific Influenza Daignostic Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Influenza Daignostic Market Size (2015-2026)
9.2 Latin America Influenza Daignostic Market Size by Type (2015-2020)
9.3 Latin America Influenza Daignostic Market Size by Application (2015-2020)
9.4 Latin America Influenza Daignostic Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Influenza Daignostic Market Size (2015-2026)
10.2 Middle East & Africa Influenza Daignostic Market Size by Type (2015-2020)
10.3 Middle East & Africa Influenza Daignostic Market Size by Application (2015-2020)
10.4 Middle East & Africa Influenza Daignostic Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Influenza Daignostic Introduction
11.1.4 Thermo Fisher Scientific Revenue in Influenza Daignostic Business (2015-2020))
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Influenza Daignostic Introduction
11.2.4 Abbott Laboratories Revenue in Influenza Daignostic Business (2015-2020)
11.2.5 Abbott Laboratories Recent Development
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Details
11.3.2 Danaher Corporation Business Overview
11.3.3 Danaher Corporation Influenza Daignostic Introduction
11.3.4 Danaher Corporation Revenue in Influenza Daignostic Business (2015-2020)
11.3.5 Danaher Corporation Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Influenza Daignostic Introduction
11.4.4 Bio-Rad Laboratories Revenue in Influenza Daignostic Business (2015-2020)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 BIOMÉRIEUX
11.5.1 BIOMÉRIEUX Company Details
11.5.2 BIOMÉRIEUX Business Overview
11.5.3 BIOMÉRIEUX Influenza Daignostic Introduction
11.5.4 BIOMÉRIEUX Revenue in Influenza Daignostic Business (2015-2020)
11.5.5 BIOMÉRIEUX Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Influenza Daignostic Introduction
11.6.4 Roche Revenue in Influenza Daignostic Business (2015-2020)
11.6.5 Roche Recent Development
11.7 Becton Dickinson And Company
11.7.1 Becton Dickinson And Company Company Details
11.7.2 Becton Dickinson And Company Business Overview
11.7.3 Becton Dickinson And Company Influenza Daignostic Introduction
11.7.4 Becton Dickinson And Company Revenue in Influenza Daignostic Business (2015-2020)
11.7.5 Becton Dickinson And Company Recent Development
11.8 Meridian Bioscience
11.8.1 Meridian Bioscience Company Details
11.8.2 Meridian Bioscience Business Overview
11.8.3 Meridian Bioscience Influenza Daignostic Introduction
11.8.4 Meridian Bioscience Revenue in Influenza Daignostic Business (2015-2020)
11.8.5 Meridian Bioscience Recent Development
11.9 Quidel Corporation
11.9.1 Quidel Corporation Company Details
11.9.2 Quidel Corporation Business Overview
11.9.3 Quidel Corporation Influenza Daignostic Introduction
11.9.4 Quidel Corporation Revenue in Influenza Daignostic Business (2015-2020)
11.9.5 Quidel Corporation Recent Development
11.10 Hologic
11.10.1 Hologic Company Details
11.10.2 Hologic Business Overview
11.10.3 Hologic Influenza Daignostic Introduction
11.10.4 Hologic Revenue in Influenza Daignostic Business (2015-2020)
11.10.5 Hologic Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Influenza Daignostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Rapid Flu Detection Test
Table 3. Key Players of Virus Detection
Table 4. Key Players of Direct Fluorescent Antibody (DFA) Test
Table 5. Key Players of Serological Testing
Table 6. Global Influenza Daignostic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Influenza Daignostic Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Influenza Daignostic Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Influenza Daignostic Market Share by Regions (2015-2020)
Table 10. Global Influenza Daignostic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Influenza Daignostic Market Share by Regions (2021-2026)
Table 12. Influenza Daignostic Market Market Trends
Table 13. Influenza Daignostic Market Drivers
Table 14. Influenza Daignostic Market Challenges
Table 15. Influenza Daignostic Market Restraints
Table 16. Global Influenza Daignostic Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Influenza Daignostic Market Share by Players (2015-2020)
Table 18. Global Top Influenza Daignostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Daignostic as of 2019)
Table 19. Global Influenza Daignostic by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Influenza Daignostic Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Influenza Daignostic Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Influenza Daignostic Revenue Market Share by Type (2015-2020)
Table 25. Global Influenza Daignostic Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 26. Global Influenza Daignostic Market Size Share by Application (2015-2020) (US$ Million)
Table 27. Global Influenza Daignostic Revenue Market Share by Application (2015-2020)
Table 28. Global Influenza Daignostic Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 29. North America Influenza Daignostic Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Influenza Daignostic Market Share by Type (2015-2020)
Table 31. North America Influenza Daignostic Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Influenza Daignostic Market Share by Application (2015-2020)
Table 33. North America Influenza Daignostic Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Influenza Daignostic Market Share by Country (2015-2020)
Table 35. Europe Influenza Daignostic Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Influenza Daignostic Market Share by Type (2015-2020)
Table 37. Europe Influenza Daignostic Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Influenza Daignostic Market Share by Application (2015-2020)
Table 39. Europe Influenza Daignostic Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Influenza Daignostic Market Share by Country (2015-2020)
Table 41. Asia-Pacific Influenza Daignostic Market Size by Type (2015-2020) (US$ Million)
Table 42. Asia-Pacific Influenza Daignostic Market Share by Type (2015-2020)
Table 43. Asia-Pacific Influenza Daignostic Market Size by Application (2015-2020) (US$ Million)
Table 44. Asia-Pacific Influenza Daignostic Market Share by Application (2015-2020)
Table 45. Asia-Pacific Influenza Daignostic Market Size by Region (US$ Million) (2015-2020)
Table 46. Asia-Pacific Influenza Daignostic Market Share by Region (2015-2020)
Table 47. Latin America Influenza Daignostic Market Size by Type (2015-2020) (US$ Million)
Table 48. Latin America Influenza Daignostic Market Share by Type (2015-2020)
Table 49. Latin America Influenza Daignostic Market Size by Application (2015-2020) (US$ Million)
Table 50. Latin America Influenza Daignostic Market Share by Application (2015-2020)
Table 51. Latin America Influenza Daignostic Market Size by Country (US$ Million) (2015-2020)
Table 52. Latin America Influenza Daignostic Market Share by Country (2015-2020)
Table 53. Middle East & Africa Influenza Daignostic Market Size by Type (2015-2020) (US$ Million)
Table 54. Middle East & Africa Influenza Daignostic Market Share by Type (2015-2020)
Table 55. Middle East & Africa Influenza Daignostic Market Size by Application (2015-2020) (US$ Million)
Table 56. Middle East & Africa Influenza Daignostic Market Share by Application (2015-2020)
Table 57. Middle East & Africa Influenza Daignostic Market Size by Country (US$ Million) (2015-2020)
Table 58. Middle East & Africa Influenza Daignostic Market Share by Country (2015-2020)
Table 59. Thermo Fisher Scientific Company Details
Table 60. Thermo Fisher Scientific Business Overview
Table 61. Thermo Fisher Scientific Influenza Daignostic Product
Table 62. Thermo Fisher Scientific Revenue in Influenza Daignostic Business (2015-2020) (US$ Million)
Table 63. Thermo Fisher Scientific Recent Development
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Influenza Daignostic Product
Table 67. Abbott Laboratories Revenue in Influenza Daignostic Business (2015-2020) (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Danaher Corporation Company Details
Table 70. Danaher Corporation Business Overview
Table 71. Danaher Corporation Influenza Daignostic Product
Table 72. Danaher Corporation Revenue in Influenza Daignostic Business (2015-2020) (US$ Million)
Table 73. Danaher Corporation Recent Development
Table 74. Bio-Rad Laboratories Company Details
Table 75. Bio-Rad Laboratories Business Overview
Table 76. Bio-Rad Laboratories Influenza Daignostic Product
Table 77. Bio-Rad Laboratories Revenue in Influenza Daignostic Business (2015-2020) (US$ Million)
Table 78. Bio-Rad Laboratories Recent Development
Table 79. BIOMÉRIEUX Company Details
Table 80. BIOMÉRIEUX Business Overview
Table 81. BIOMÉRIEUX Influenza Daignostic Product
Table 82. BIOMÉRIEUX Revenue in Influenza Daignostic Business (2015-2020) (US$ Million)
Table 83. BIOMÉRIEUX Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Influenza Daignostic Product
Table 87. Roche Revenue in Influenza Daignostic Business (2015-2020) (US$ Million)
Table 88. Roche Recent Development
Table 89. Becton Dickinson And Company Company Details
Table 90. Becton Dickinson And Company Business Overview
Table 91. Becton Dickinson And Company Influenza Daignostic Product
Table 92. Becton Dickinson And Company Revenue in Influenza Daignostic Business (2015-2020) (US$ Million)
Table 93. Becton Dickinson And Company Recent Development
Table 94. Meridian Bioscience Business Overview
Table 95. Meridian Bioscience Influenza Daignostic Product
Table 96. Meridian Bioscience Company Details
Table 97. Meridian Bioscience Revenue in Influenza Daignostic Business (2015-2020) (US$ Million)
Table 98. Meridian Bioscience Recent Development
Table 99. Quidel Corporation Company Details
Table 100. Quidel Corporation Business Overview
Table 101. Quidel Corporation Influenza Daignostic Product
Table 102. Quidel Corporation Revenue in Influenza Daignostic Business (2015-2020) (US$ Million)
Table 103. Quidel Corporation Recent Development
Table 104. Hologic Company Details
Table 105. Hologic Business Overview
Table 106. Hologic Influenza Daignostic Product
Table 107. Hologic Revenue in Influenza Daignostic Business (2015-2020) (US$ Million)
Table 108. Hologic Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Influenza Daignostic Market Share by Type: 2020 VS 2026
Figure 2. Rapid Flu Detection Test Features
Figure 3. Virus Detection Features
Figure 4. Direct Fluorescent Antibody (DFA) Test Features
Figure 5. Serological Testing Features
Figure 6. Global Influenza Daignostic Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Influenza Daignostic Report Years Considered
Figure 11. Global Influenza Daignostic Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Influenza Daignostic Market Share by Regions: 2020 VS 2026
Figure 13. Global Influenza Daignostic Market Share by Regions (2021-2026)
Figure 14. Global Influenza Daignostic Market Share by Players in 2019
Figure 15. Global Top Influenza Daignostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Daignostic as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Influenza Daignostic Revenue in 2019
Figure 17. North America Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Influenza Daignostic Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Thermo Fisher Scientific Revenue Growth Rate in Influenza Daignostic Business (2015-2020)
Figure 43. Abbott Laboratories Revenue Growth Rate in Influenza Daignostic Business (2015-2020)
Figure 44. Danaher Corporation Revenue Growth Rate in Influenza Daignostic Business (2015-2020)
Figure 45. Bio-Rad Laboratories Revenue Growth Rate in Influenza Daignostic Business (2015-2020)
Figure 46. BIOMÉRIEUX Revenue Growth Rate in Influenza Daignostic Business (2015-2020)
Figure 47. Roche Revenue Growth Rate in Influenza Daignostic Business (2015-2020)
Figure 48. Becton Dickinson And Company Revenue Growth Rate in Influenza Daignostic Business (2015-2020)
Figure 49. Meridian Bioscience Revenue Growth Rate in Influenza Daignostic Business (2015-2020)
Figure 50. Quidel Corporation Revenue Growth Rate in Influenza Daignostic Business (2015-2020)
Figure 51. Hologic Revenue Growth Rate in Influenza Daignostic Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed